DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Kronox Lab Sciences Limited — Updates

NSE 1 hr ago·29 Sept 2026, 12:20 pm

Kronox LAB Sciences

Kronox Lab Sciences Limited has informed stock exchanges that it has received an intimation under SEBI's Regulation 31(A). This regulation requires listed companies to disclose material information to investors as soon as it is determined by the board of directors.

This update signals that the company has identified a significant development that could impact its business or financial standing. For investors, this serves as a reminder to monitor the company's official filings for the full details of the announcement.

Investors should watch for the specific nature of the intimation and the company's subsequent clarification. Until the details are disclosed, the market will likely await further information to understand the potential implications for the stock.